<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35038922</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2150-7511</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>mBio</Title><ISOAbbreviation>mBio</ISOAbbreviation></Journal><ArticleTitle>Cross-Reactive Antibody Responses against Nonpoliovirus Enteroviruses.</ArticleTitle><Pagination><StartPage>e0366021</StartPage><MedlinePgn>e0366021</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e03660-21</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/mbio.03660-21</ELocationID><Abstract><AbstractText>Enteroviruses are among the most common human viral pathogens. Infection with members of a subgroup of viruses within this genus, the nonpoliovirus enteroviruses (NPEVs), can result in a broad spectrum of serious illnesses, including acute flaccid myelitis (AFM), a polio-like childhood paralysis; neonatal sepsis; aseptic meningitis; myocarditis; and hand-foot-mouth disease. Despite the diverse primary sites of virus infection, including the respiratory and alimentary tracts, and an array of diseases associated with these infections, there is significant genetic and antigenic similarity among NPEVs. This conservation results in the induction of cross-reactive antibodies that are either able to bind and neutralize or bind but not neutralize multiple NPEVs. Using plaque reduction and enzyme-linked immunosorbent assay (ELISA)-based binding assays, we define the antigenic relationship among poliovirus and NPEVs, including multiple isolates of EV-D68, EV-A71, EV-D70, EV-94, EV-111, Coxsackievirus A24v, and rhinovirus. The results reveal extensive cross-reactivity among EVs that cannot be predicted from phylogenetic analysis. Determining the immunologic relationship among EVs is critical to understanding the humoral response elicited during homologous and heterologous virus infections. <b>IMPORTANCE</b> Enteroviruses (EVs) are common human pathogens. Although infection with EVs leads to cross-reactive antibodies, the clinical relevance of these antibodies is unclear given the estimated incidence of EV infections in the general population of one per year. The hypothesis that anti-EV cross-reactive antibodies can bind and neutralize heterologous EVs was investigated using polyclonal sera collected from animals immunized with individual EVs. Both binding and neutralization activities against heterologous EVs was observed in these sera, and we speculate that cross-reactive antibodies may modulate infection and disease severity. Defining the antigenic relationship among EVs may provide insights into the epidemiology and pathogenesis of enterovirus infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rosenfeld</LastName><ForeName>Amy B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Vagelos College of Physicians and Surgeons, Columbia Universitygrid.239585.0grid.21729.3f, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Edmund Qian Long</ForeName><Initials>EQL</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Vagelos College of Physicians and Surgeons, Columbia Universitygrid.239585.0grid.21729.3f, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melendez</LastName><ForeName>Michaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Vagelos College of Physicians and Surgeons, Columbia Universitygrid.239585.0grid.21729.3f, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mishra</LastName><ForeName>Nischay</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Department of Epidemiology, Mailman School of Public Health, Columbia Universitygrid.239585.0grid.21729.3f, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipkin</LastName><ForeName>W Ian</ForeName><Initials>WI</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Department of Epidemiology, Mailman School of Public Health, Columbia Universitygrid.239585.0grid.21729.3f, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Racaniello</LastName><ForeName>Vincent R</ForeName><Initials>VR</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Vagelos College of Physicians and Surgeons, Columbia Universitygrid.239585.0grid.21729.3f, New York, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 AI151996</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AI069470</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 AI069470</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>mBio</MedlineTA><NlmUniqueID>101519231</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000906">Antibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>mBio. 2022 Jun 28;13(3):e0045722. doi: 10.1128/mbio.00457-22</RefSource><PMID Version="1">35658549</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000917" MajorTopicYN="N">Antibody Formation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000906" MajorTopicYN="N">Antibodies</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antibody</Keyword><Keyword MajorTopicYN="N">antigenic variation</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">poliovirus</Keyword><Keyword MajorTopicYN="N">serotype</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>18</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35038922</ArticleId><ArticleId IdType="pmc">PMC8764532</ArticleId><ArticleId IdType="doi">10.1128/mbio.03660-21</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Royston L, Geiser J, Josset L, Schuffenecker I, Tapparel C. 2017. A new real-time RT-PCR targeting VP4-VP2 to detect and quantify enterovirus D68 in respiratory samples. J Med Virol 89:1879–1881. doi:10.1002/jmv.24778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24778</ArticleId><ArticleId IdType="pubmed">28169437</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S, Chidini G, Cinnante C, Napolitano L, Giannini A, Terranova L, Niesters H, Principi N, Calderini E. 2017. Acute flaccid myelitis associated with enterovirus-D68 infection in an otherwise healthy child. Virol J 14:4. doi:10.1186/s12985-016-0678-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-016-0678-0</ArticleId><ArticleId IdType="pmc">PMC5234096</ArticleId><ArticleId IdType="pubmed">28081720</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang TG, Li HQ, Li AH, Chen M, Gong C, Luo M, Dong M, Huang F. 2016. The genomic characterization of enterovirus D68 from 2011 to 2015 in Beijing, China. Biomed Environ Sci 29:675–677. doi:10.3967/bes2016.089.</Citation><ArticleIdList><ArticleId IdType="doi">10.3967/bes2016.089</ArticleId><ArticleId IdType="pubmed">27806749</ArticleId></ArticleIdList></Reference><Reference><Citation>Greninger AL, Naccache SN, Messacar K, Clayton A, Yu G, Somasekar S, Federman S, Stryke D, Anderson C, Yagi S, Messenger S, Wadford D, Xia D, Watt JP, Van Haren K, Dominguez SR, Glaser C, Aldrovandi G, Chiu CY. 2015. A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012–14): a retrospective cohort study. Lancet Infect Dis 15:671–682. 10.1016/S1473-3099(15)70093-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)70093-9</ArticleId><ArticleId IdType="pmc">PMC6027625</ArticleId><ArticleId IdType="pubmed">25837569</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y, Hassan F, Schuster JE, Simenauer A, Selvarangan R, Halpin RA, Lin X, Fedorova N, Stockwell TB, Lam TT, Chappell JD, Hartert TV, Holmes EC, Das SR. 2016. Molecular evolution and intraclade recombination of enterovirus D68 during the 2014 outbreak in the United States. J Virol 90:1997–2007. doi:10.1128/JVI.02418-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02418-15</ArticleId><ArticleId IdType="pmc">PMC4733988</ArticleId><ArticleId IdType="pubmed">26656685</ArticleId></ArticleIdList></Reference><Reference><Citation>Fendrick AM, Monto AS, Nightengale B, Sarnes M. 2003. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med 163:487–494. doi:10.1001/archinte.163.4.487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.163.4.487</ArticleId><ArticleId IdType="pubmed">12588210</ArticleId></ArticleIdList></Reference><Reference><Citation>Nhan LNT, Turner HC, Khanh TH, Hung NT, Lien LB, Hong NTT, Nhu LNT, Ny NTH, Nguyet LA, Thanh TT, Van HMT, Viet HL, Tung TH, Phuong TTL, Devine A, Thwaites G, Chau NVV, Thwaites L, van Doorn HR, Tan LV. 2019. Economic burden attributed to children presenting to hospitals with hand, foot, and mouth disease in Vietnam. Open Forum Infect Dis 6:ofz284. 10.1093/ofid/ofz284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofz284</ArticleId><ArticleId IdType="pmc">PMC6657964</ArticleId><ArticleId IdType="pubmed">31363772</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeuh-Mba SA, Joffret ML, Mazitchi A, Endegue-Zanga MC, Njouom R, Delpeyroux F, Gouandjika-Vasilache I, Bessaud M. 2019. Genetic and phenotypic characterization of recently discovered enterovirus D type 111. PLoS Negl Trop Dis 13:e0007797. doi:10.1371/journal.pntd.0007797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0007797</ArticleId><ArticleId IdType="pmc">PMC6818792</ArticleId><ArticleId IdType="pubmed">31622358</ArticleId></ArticleIdList></Reference><Reference><Citation>Smura T, Blomqvist S, Paananen A, Vuorinen T, Sobotova Z, Bubovica V, Ivanova O, Hovi T, Roivainen M. 2007. Enterovirus surveillance reveals proposed new serotypes and provides new insight into enterovirus 5'-untranslated region evolution. J Gen Virol 88:2520–2526. doi:10.1099/vir.0.82866-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.82866-0</ArticleId><ArticleId IdType="pubmed">17698662</ArticleId></ArticleIdList></Reference><Reference><Citation>Faleye TOC, Adewumi MO, Japhet MO, David OM, Oluyege AO, Adeniji JA, Famurewa O. 2017. Non-polio enteroviruses in faeces of children diagnosed with acute flaccid paralysis in Nigeria. Virol J 14:175. doi:10.1186/s12985-017-0846-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-017-0846-x</ArticleId><ArticleId IdType="pmc">PMC5596853</ArticleId><ArticleId IdType="pubmed">28899411</ArticleId></ArticleIdList></Reference><Reference><Citation>Luchs A, Leal E, Tardy K, Milagres FAP, Komninakis SV, Brustulin R, Teles M, Lobato M, das Chagas RT, Abrao M, Soares C, Deng X, Delwart E, Sabino EC, da Costa AC. 2019. The rare enterovirus c99 and echovirus 29 strains in Brazil: potential risks associated to silent circulation. Mem Inst Oswaldo Cruz 114:e190160. doi:10.1590/0074-02760190160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0074-02760190160</ArticleId><ArticleId IdType="pmc">PMC6690645</ArticleId><ArticleId IdType="pubmed">31411312</ArticleId></ArticleIdList></Reference><Reference><Citation>Mombo IM, Berthet N, Lukashev AN, Bleicker T, Brunink S, Leger L, Atencia R, Cox D, Bouchier C, Durand P, Arnathau C, Brazier L, Fair JN, Schneider BS, Drexler JF, Prugnolle F, Drosten C, Renaud F, Leroy EM, Rougeron V. 2015. First detection of an enterovirus C99 in a captive chimpanzee with acute flaccid paralysis, from the Tchimpounga Chimpanzee Rehabilitation Center, Republic of Congo. PLoS One 10:e0136700. doi:10.1371/journal.pone.0136700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0136700</ArticleId><ArticleId IdType="pmc">PMC4547728</ArticleId><ArticleId IdType="pubmed">26301510</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeuh-Mba SA, Bessaud M, Joffret ML, Endegue Zanga MC, Balanant J, Mpoudi Ngole E, Njouom R, Reynes JM, Delpeyroux F, Rousset D. 2014. Characterization of enteroviruses from non-human primates in Cameroon revealed virus types widespread in humans along with candidate new types and species. PLoS Negl Trop Dis 8:e3052. doi:10.1371/journal.pntd.0003052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003052</ArticleId><ArticleId IdType="pmc">PMC4117447</ArticleId><ArticleId IdType="pubmed">25079078</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens DM, Folkers GK, Fauci AS. 2019. Acute flaccid myelitis: something old and something new. mBio 10:e00521-19. doi:10.1128/mBio.00521-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00521-19</ArticleId><ArticleId IdType="pmc">PMC6445942</ArticleId><ArticleId IdType="pubmed">30940708</ArticleId></ArticleIdList></Reference><Reference><Citation>Scully EJ, Basnet S, Wrangham RW, Muller MN, Otali E, Hyeroba D, Grindle KA, Pappas TE, Thompson ME, Machanda Z, Watters KE, Palmenberg AC, Gern JE, Goldberg TL. 2018. Lethal respiratory disease associated with human rhinovirus C in wild chimpanzees, Uganda, 2013. Emerg Infect Dis 24:267–274. doi:10.3201/eid2402.170778.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2402.170778</ArticleId><ArticleId IdType="pmc">PMC5782908</ArticleId><ArticleId IdType="pubmed">29350142</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison CJ, Weldon WC, Pahud BA, Jackson MA, Oberste MS, Selvarangan R. 2019. Neutralizing antibody against enterovirus D68 in children and adults before 2014 outbreak, Kansas City, Missouri, USA. Emerg Infect Dis 25:585–588. doi:10.3201/eid2503.180960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2503.180960</ArticleId><ArticleId IdType="pmc">PMC6390745</ArticleId><ArticleId IdType="pubmed">30789123</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Moore DD, Nix WA, Oberste MS, Weldon WC. 2015. Neutralization of enterovirus D68 isolated from the 2014 US outbreak by commercial intravenous immune globulin products. J Clin Virol 69:172–175. doi:10.1016/j.jcv.2015.06.086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.06.086</ArticleId><ArticleId IdType="pmc">PMC6512324</ArticleId><ArticleId IdType="pubmed">26209401</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JT, Shih WL, Yen TY, Cheng AL, Lu CY, Chang LY, Huang LM. 2020. Enterovirus D68 seroepidemiology in Taiwan, a cross sectional study from 2017. PLoS One 15:e0230180. doi:10.1371/journal.pone.0230180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0230180</ArticleId><ArticleId IdType="pmc">PMC7064212</ArticleId><ArticleId IdType="pubmed">32155216</ArticleId></ArticleIdList></Reference><Reference><Citation>Karelehto E, Koen G, Benschop K, van der Klis F, Pajkrt D, Wolthers K. 2019. Enterovirus D68 serosurvey: evidence for endemic circulation in the Netherlands, 2006 to 2016. Euro Surveill 24:1800671. 10.2807/1560-7917.ES.2019.24.35.1800671.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2019.24.35.1800671</ArticleId><ArticleId IdType="pmc">PMC6724466</ArticleId><ArticleId IdType="pubmed">31481149</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt MR, Crowe JE, Jr.. 2018. Current understanding of humoral immunity to enterovirus D68. J Pediatric Infect Dis Soc 7:S49–S53. doi:10.1093/jpids/piy124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piy124</ArticleId><ArticleId IdType="pubmed">30590621</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao LY, Pierce C, Gray-Johnson J, DeLotell J, Shaw C, Chapman N, Yeh E, Schnurr D, Huang YT. 2009. Monoclonal antibodies to VP1 recognize a broad range of enteroviruses. J Clin Microbiol 47:3108–3113. doi:10.1128/JCM.00479-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00479-09</ArticleId><ArticleId IdType="pmc">PMC2756915</ArticleId><ArticleId IdType="pubmed">19710278</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuelson A, Forsgren M, Johansson B, Wahren B, Sallberg M. 1994. Molecular basis for serological cross-reactivity between enteroviruses. Clin Diagn Lab Immunol 1:336–341. doi:10.1128/cdli.1.3.336-341.1994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cdli.1.3.336-341.1994</ArticleId><ArticleId IdType="pmc">PMC368258</ArticleId><ArticleId IdType="pubmed">7496972</ArticleId></ArticleIdList></Reference><Reference><Citation>Cello J, Samuelson A, Stalhandske P, Svennerholm B, Jeansson S, Forsgren M. 1993. Identification of group-common linear epitopes in structural and nonstructural proteins of enteroviruses by using synthetic peptides. J Clin Microbiol 31:911–916. doi:10.1128/jcm.31.4.911-916.1993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.31.4.911-916.1993</ArticleId><ArticleId IdType="pmc">PMC263586</ArticleId><ArticleId IdType="pubmed">7681848</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuelson A, Forsgren M, Sallberg M. 1995. Characterization of the recognition site and diagnostic potential of an enterovirus group-reactive monoclonal antibody. Clin Diagn Lab Immunol 2:385–386. doi:10.1128/cdli.2.3.385-386.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cdli.2.3.385-386.1995</ArticleId><ArticleId IdType="pmc">PMC170165</ArticleId><ArticleId IdType="pubmed">7545081</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuelson A, Johansson B, Forsgren M. 1995. Sequence analysis of echoviruses in a major antigenic region eliciting enteroviral cross-reactive antibodies. Arch Virol 140:2085–2091. doi:10.1007/BF01322695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01322695</ArticleId><ArticleId IdType="pubmed">7503704</ArticleId></ArticleIdList></Reference><Reference><Citation>Saarinen NVV, Lehtonen J, Veijola R, Lempainen J, Knip M, Hyoty H, Laitinen OH, Hytonen VP. 2020. Multiplexed high-throughput serological assay for human enteroviruses. Microorganisms 8:963. doi:10.3390/microorganisms8060963.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8060963</ArticleId><ArticleId IdType="pmc">PMC7355947</ArticleId><ArticleId IdType="pubmed">32604930</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovi T, Roivainen M. 1993. Peptide antisera targeted to a conserved sequence in poliovirus capsid VP1 cross-react widely with members of the genus Enterovirus. J Clin Microbiol 31:1083–1087. doi:10.1128/jcm.31.5.1083-1087.1993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.31.5.1083-1087.1993</ArticleId><ArticleId IdType="pmc">PMC262883</ArticleId><ArticleId IdType="pubmed">8388885</ArticleId></ArticleIdList></Reference><Reference><Citation>Emini EA, Jameson BA, Wimmer E. 1983. Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature 304:699–703. doi:10.1038/304699a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/304699a0</ArticleId><ArticleId IdType="pubmed">6310403</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul JR, Trask JD. 1935. The neutralization test in poliomyelitis: comparative results with four strains of the virus. J Exp Med 61:447–464. doi:10.1084/jem.61.4.447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.61.4.447</ArticleId><ArticleId IdType="pmc">PMC2133235</ArticleId><ArticleId IdType="pubmed">19870370</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart FW, Rhoads CP. 1929. Intradermal versus subcutaneous immunization of monkeys against poliomyelitis. J Exp Med 49:959–973. doi:10.1084/jem.49.6.959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.49.6.959</ArticleId><ArticleId IdType="pmc">PMC2131593</ArticleId><ArticleId IdType="pubmed">19869595</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnet FM, Macnamara J. 1931. Immunological differences between strains of poliomyelitic virus. Br J Exp Pathol XII:57–61.</Citation></Reference><Reference><Citation>Wenner HA, Miller CA, Wilson JC. 1953. Immunologic classification of poliomyelitis viruses. VI. Results of typing by neutralization of prototype viruses with antiserum for the unknown strains. A. Studies from the University of Kansas on sixty-seven strains. Am J Hyg 58:52–64.</Citation><ArticleIdList><ArticleId IdType="pubmed">13065272</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Fischer ER, Kouiavskaia D, Hansen BT, Ludtke SJ, Bidzhieva B, Makiya M, Agulto L, Purcell RH, Chumakov K. 2013. Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor. Proc Natl Acad Sci USA 110:20242–20247. doi:10.1073/pnas.1320041110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1320041110</ArticleId><ArticleId IdType="pmc">PMC3864303</ArticleId><ArticleId IdType="pubmed">24277851</ArticleId></ArticleIdList></Reference><Reference><Citation>Harber J, Bernhardt G, Lu HH, Sgro JY, Wimmer E. 1995. Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor. Virology 214:559–570. doi:10.1006/viro.1995.0067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1995.0067</ArticleId><ArticleId IdType="pubmed">8553558</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleet WF, Couch RB, Cate TR, Knight V. 1965. Homologous and heterologous resistance to rhinovirus common cold. Am J Epidemiol 82:185–196. doi:10.1093/oxfordjournals.aje.a120543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a120543</ArticleId><ArticleId IdType="pubmed">4283952</ArticleId></ArticleIdList></Reference><Reference><Citation>Katpally U, Fu TM, Freed DC, Casimiro DR, Smith TJ. 2009. Antibodies to the buried N terminus of rhinovirus VP4 exhibit cross-serotypic neutralization. J Virol 83:7040–7048. doi:10.1128/JVI.00557-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00557-09</ArticleId><ArticleId IdType="pmc">PMC2704786</ArticleId><ArticleId IdType="pubmed">19403680</ArticleId></ArticleIdList></Reference><Reference><Citation>Edlmayr J, Niespodziana K, Popow-Kraupp T, Krzyzanek V, Focke-Tejkl M, Blaas D, Grote M, Valenta R. 2011. Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation. Eur Respir J 37:44–52. doi:10.1183/09031936.00149109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00149109</ArticleId><ArticleId IdType="pubmed">20530036</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Cheng T, Zhu F, Li J, Wang Y, Li Y, Gao F, Yang L, Yao X, Shao J, Xia N, Liang Z, Wang J. 2013. The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy Chinese infants and children. PLoS One 8:e79599. doi:10.1371/journal.pone.0079599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079599</ArticleId><ArticleId IdType="pmc">PMC3834186</ArticleId><ArticleId IdType="pubmed">24260259</ArticleId></ArticleIdList></Reference><Reference><Citation>Phanthong S, Densumite J, Seesuay W, Thanongsaksrikul J, Teimoori S, Sookrung N, Poovorawan Y, Onvimala N, Guntapong R, Pattanapanyasat K, Chaicumpa W. 2020. Human Antibodies to VP4 inhibit replication of enteroviruses across subgenotypes and serotypes, and enhance host innate immunity. Front Microbiol 11:562768. doi:10.3389/fmicb.2020.562768.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.562768</ArticleId><ArticleId IdType="pmc">PMC7545151</ArticleId><ArticleId IdType="pubmed">33101238</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra N, Ng TFF, Marine RL, Jain K, Ng J, Thakkar R, Caciula A, Price A, Garcia JA, Burns JC, Thakur KT, Hetzler KL, Routh JA, Konopka-Anstadt JL, Nix WA, Tokarz R, Briese T, Oberste MS, Lipkin WI. 2019. Antibodies to enteroviruses in cerebrospinal fluid of patients with acute flaccid myelitis. mBio 10:e01903-19. 10.1128/mBio.01903-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01903-19</ArticleId><ArticleId IdType="pmc">PMC6692520</ArticleId><ArticleId IdType="pubmed">31409689</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert RD, Hawes IA, Ramachandran PS, Ramesh A, Crawford ED, Pak JE, Wu W, Cheung CK, O’Donovan BD, Tato CM, Lyden A, Tan M, Sit R, Sowa GA, Sample HA, Zorn KC, Banerji D, Khan LM, Bove R, Hauser SL, Gelfand AA, Johnson-Kerner BL, Nash K, Krishnamoorthy KS, Chitnis T, Ding JZ, McMillan HJ, Chiu CY, Briggs B, Glaser CA, Yen C, Chu V, Wadford DA, Dominguez SR, Ng TFF, Marine RL, Lopez AS, Nix WA, Soldatos A, Gorman MP, Benson L, Messacar K, Konopka-Anstadt JL, Oberste MS, DeRisi JL, Wilson MR. 2019. Pan-viral serology implicates enteroviruses in acute flaccid myelitis. Nat Med 25:1748–1752. doi:10.1038/s41591-019-0613-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0613-1</ArticleId><ArticleId IdType="pmc">PMC6858576</ArticleId><ArticleId IdType="pubmed">31636453</ArticleId></ArticleIdList></Reference><Reference><Citation>Smura T, Ylipaasto P, Klemola P, Kaijalainen S, Kyllonen L, Sordi V, Piemonti L, Roivainen M. 2010. Cellular tropism of human enterovirus D species serotypes EV-94, EV-70, and EV-68 in vitro: implications for pathogenesis. J Med Virol 82:1940–1949. doi:10.1002/jmv.21894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21894</ArticleId><ArticleId IdType="pubmed">20872722</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Salort M, Grassly NC. 2018. Serotype-specific immunity explains the incidence of diseases caused by human enteroviruses. Science 361:800–803. doi:10.1126/science.aat6777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat6777</ArticleId><ArticleId IdType="pmc">PMC6559928</ArticleId><ArticleId IdType="pubmed">30139872</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow M, Baltimore D. 1982. Isolated poliovirus capsid protein VP1 induces a neutralizing response in rats. Proc Natl Acad Sci USA 79:7518–7521. doi:10.1073/pnas.79.23.7518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.79.23.7518</ArticleId><ArticleId IdType="pmc">PMC347371</ArticleId><ArticleId IdType="pubmed">6296837</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt MR, Fu J, Kose N, Williamson LE, Bombardi R, Setliff I, Georgiev IS, Klose T, Rossmann MG, Bochkov YA, Gern JE, Kuhn RJ, Crowe JE, Jr.. 2020. Human antibodies neutralize enterovirus D68 and protect against infection and paralytic disease. Sci Immunol 5:eaba4902. 10.1126/sciimmunol.aba4902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aba4902</ArticleId><ArticleId IdType="pmc">PMC7418079</ArticleId><ArticleId IdType="pubmed">32620559</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenfeld AB, Racaniello VR. 2021. Picornaviridae: the viruses and their replication, p 30–85, Fields virology: Emerging Viruses, 7th ed, vol 1. Wolters Kluwer, Philadelphia, PA.</Citation></Reference><Reference><Citation>Hogle JM. 1982. Preliminary studies of crystals of poliovirus type I. J Mol Biol 160:663–668. doi:10.1016/0022-2836(82)90322-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-2836(82)90322-9</ArticleId><ArticleId IdType="pubmed">6294308</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossmann MG. 1989. The canyon hypothesis: hiding the host cell receptor attachment site on a viral surface from immune surveillance. J Biol Chem 264:14587–14590. doi:10.1016/S0021-9258(18)63732-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)63732-9</ArticleId><ArticleId IdType="pubmed">2670920</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson JW, Frankenberger EA, Rossmann MG, Fout GS, Medappa KC, Rueckert RR. 1983. Crystallization of a common cold virus, human rhinovirus 14: “isomorphism” with poliovirus crystals. Proc Natl Acad Sci USA 80:931–934. doi:10.1073/pnas.80.4.931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.80.4.931</ArticleId><ArticleId IdType="pmc">PMC393501</ArticleId><ArticleId IdType="pubmed">6302674</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Zheng Q, Li S, He M, Wu Y, Li Y, Zhu R, Yu H, Hong Q, Jiang J, Li Z, Li S, Zhao H, Yang L, Hou W, Wang W, Ye X, Zhang J, Baker TS, Cheng T, Zhou ZH, Yan X, Xia N. 2017. Atomic structures of coxsackievirus A6 and its complex with a neutralizing antibody. Nat Commun 8:505. doi:10.1038/s41467-017-00477-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00477-9</ArticleId><ArticleId IdType="pmc">PMC5593947</ArticleId><ArticleId IdType="pubmed">28894095</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogle JM, Filman DJ. 1989. The antigenic structure of poliovirus. Philos Trans R Soc Lond B Biol Sci 323:467–478. doi:10.1098/rstb.1989.0024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.1989.0024</ArticleId><ArticleId IdType="pubmed">2569204</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Song Z, Yu H, Zhang X, Xu S, Li Z, Li J, Xu H, Yuan Z, Ma H, Yi Z, Hu Y. 2018. Genome-wide linear B-cell epitopes of enterovirus 71 in a hand, foot and mouth disease (HFMD) population. J Clin Virol 105:41–48. doi:10.1016/j.jcv.2018.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.06.001</ArticleId><ArticleId IdType="pubmed">29886372</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv H, Wu NC, Tsang OT, Yuan M, Perera R, Leung WS, So RTY, Chan JMC, Yip GK, Chik TSH, Wang Y, Choi CYC, Lin Y, Ng WW, Zhao J, Poon LLM, Peiris JSM, Wilson IA, Mok CKP. 2020. Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections. Cell Rep 31:107725. doi:10.1016/j.celrep.2020.107725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107725</ArticleId><ArticleId IdType="pmc">PMC7231734</ArticleId><ArticleId IdType="pubmed">32426212</ArticleId></ArticleIdList></Reference><Reference><Citation>Coudere K, van der Straten K, Brouwer L, Koen G, van Eijk H, Pajkrt D, Murk JL, Wolthers KC. 2021. Neutralising antibodies against enterovirus and parechovirus in IVIG reflect general circulation: a tool for sero-surveillance. Viruses 13:1028. doi:10.3390/v13061028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13061028</ArticleId><ArticleId IdType="pmc">PMC8228535</ArticleId><ArticleId IdType="pubmed">34072486</ArticleId></ArticleIdList></Reference><Reference><Citation>Galama JM, Vogels MT, Jansen GH, Gielen M, Heessen FW. 1997. Antibodies against enteroviruses in intravenous Ig preparations: great variation in titres and poor correlation with the incidence of circulating serotypes. J Med Virol 53:273–276. doi:10.1002/(SICI)1096-9071(199711)53:3&lt;273::AID-JMV16&gt;3.0.CO;2-I.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9071(199711)53:3&lt;273::AID-JMV16&gt;3.0.CO;2-I</ArticleId><ArticleId IdType="pubmed">9365895</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottiger M. 1990. Polio immunity to killed vaccine: an 18-year follow-up. Vaccine 8:443–445. doi:10.1016/0264-410X(90)90244-G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0264-410X(90)90244-G</ArticleId><ArticleId IdType="pubmed">2251870</ArticleId></ArticleIdList></Reference><Reference><Citation>Faden H, Duffy L, Sun M, Shuff C. 1993. Long-term immunity to poliovirus in children immunized with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines. J Infect Dis 168:452–454. doi:10.1093/infdis/168.2.452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/168.2.452</ArticleId><ArticleId IdType="pubmed">8335983</ArticleId></ArticleIdList></Reference><Reference><Citation>Nates SV, Martinez LC, Barril PA, Ferreyra LJ, Giordano MO, Masachessi G, Isa MB. 2007. Long-lasting poliovirus-neutralizing antibodies among Argentinean population immunized with four or five oral polio vaccine doses 1 month to 19 years previously. Viral Immunol 20:3–10. doi:10.1089/vim.2006.0071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2006.0071</ArticleId><ArticleId IdType="pubmed">17425416</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelsohn C, Johnson B, Lionetti KA, Nobis P, Wimmer E, Racaniello VR. 1986. Transformation of a human poliovirus receptor gene into mouse cells. Proc Natl Acad Sci USA 83:7845–7849. doi:10.1073/pnas.83.20.7845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.83.20.7845</ArticleId><ArticleId IdType="pmc">PMC386819</ArticleId><ArticleId IdType="pubmed">3020560</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MS, Racaniello VR. 2007. Enterovirus 70 receptor utilization is controlled by capsid residues that also regulate host range and cytopathogenicity. J Virol 81:8648–8655. doi:10.1128/JVI.01569-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01569-06</ArticleId><ArticleId IdType="pmc">PMC1951352</ArticleId><ArticleId IdType="pubmed">17537857</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>